Literature DB >> 35673918

[Identification of serological biomarkers for diagnosis of rheumatoid arthritis using a protein array-based approach].

Y Han1, X Lu1, W Lai1, R Liang1, M Yang1, Q Ouyang1.   

Abstract

OBJECTIVE: To study the cytokine patterns in patients with rheumatoid arthritis (RA) and healthy individuals and identify candidate serum biomarkers for clinical diagnosis of RA.
METHODS: This study was conducted among 59 patients diagnosed with RA in our hospital from 2015 to 2019 with 46 age- and gender-matched healthy subjects who received regular physical examinations in our hospital as the control group. Serological autoimmune profiles of 5 RA patients and 5 healthy control subjects were obtained from human cytokine microarrays. We selected 4 differentially expressed cytokines (LIMPII, ROBO3, Periostin and IGFBP-4) and 2 soluble cytokine receptors of interest (2B4 and Tie-2) and examined their serum levels using enzyme-linked immunosorbent assay in 54 RA patients and 41 healthy control subjects. Spearman correlation test was performed to assess the correlation of serum cytokine and soluble receptor expression levels with the clinical features including rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), disease activity score (DAS28) and health assessment questionnaire (HAQ). Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic capability of these cytokines.
RESULTS: We identified 6 dysregulated cytokines and soluble receptors (2B4, LIMPII, Tie-2, ROBO3, periostin and IGFBP-4) in RA patients (P < 0.01). The serum levels of LIMPII, ROBO3 and periostin were significantly correlated with the disease activity indicators including RF (P < 0.001), CRP (P < 0.001), DAS28 (P < 0.001) and HAQ (P < 0.001) in RA patients. Among the 6 candidate cytokines, 2B4 showed the largest area under the curve (AUC) of 0.861 for RA diagnosis (P < 0.001), followed then by LIMPII, ROBO3, periostin, Tie-2 and IGFBP-4.
CONCLUSION: Serum levels of LIMPII, ROBO3 and periostin can be indicative of the disease activity of RA, and serum 2B4, LIMPII, periostin, ROBO3, IGFBP-4 and Tie-2 levels may serve as biomarkers for the diagnosis of RA.

Entities:  

Keywords:  biomarkers; cytokine; cytokine receptor; protein chip; rheumatoid arthritis

Mesh:

Substances:

Year:  2022        PMID: 35673918      PMCID: PMC9178634          DOI: 10.12122/j.issn.1673-4254.2022.05.15

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  29 in total

1.  Positive association between serum thymic stromal lymphopoietin and anti-citrullinated peptide antibodies in patients with rheumatoid arthritis.

Authors:  K Koyama; T Ohba; H Haro; A Nakao
Journal:  Clin Exp Immunol       Date:  2015-08       Impact factor: 4.330

2.  Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria.

Authors:  Karin Britsemmer; Jennie Ursum; Martijn Gerritsen; L H van Tuyl; Lilian van Tuyl; Dirkjan van Schaardenburg
Journal:  Ann Rheum Dis       Date:  2011-05-17       Impact factor: 19.103

Review 3.  2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.

Authors:  Megan E McNerney; Kyung-Mi Lee; Vinay Kumar
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

4.  Identification and characterization of a major lysosomal membrane glycoprotein, LGP85/LIMP II in mouse liver.

Authors:  N Tabuchi; K Akasaki; T Sasaki; N Kanda; H Tsuji
Journal:  J Biochem       Date:  1997-10       Impact factor: 3.387

5.  RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll-like receptor signaling pathway.

Authors:  Xumin Hu; Jianhua Tang; Gang Zeng; Xuyun Hu; Peng Bao; Jionglin Wu; Yuwei Liang; Weixi Deng; Yong Tang
Journal:  J Cell Physiol       Date:  2019-04-22       Impact factor: 6.384

Review 6.  Cytokines in rheumatoid arthritis - shaping the immunological landscape.

Authors:  Iain B McInnes; Christopher D Buckley; John D Isaacs
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

7.  Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.

Authors:  T Matsumoto; S E Gargosky; K Iwasaki; R G Rosenfeld
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

8.  [Value of four serum markers in the diagnosis of rheumatoid arthritis].

Authors:  Xingang Zhang; Li Jiang; Xiaoli Zhang; Yun Guo; Tao Shen; Xiaofei Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2013-04

9.  1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes.

Authors:  Xin Gu; Bingjie Gu; Xianhui Lv; Zhenzhen Yu; Rong Wang; Xiaoli Zhou; Wanxin Qiao; Zhiyuan Mao; Guoping Zuo; Qing Li; Dengshun Miao; Jianliang Jin
Journal:  Cell Death Dis       Date:  2016-10-20       Impact factor: 8.469

10.  Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.

Authors:  Masaru Takeshita; Katsuya Suzuki; Yasushi Kondo; Rimpei Morita; Yuumi Okuzono; Keiko Koga; Yoshiaki Kassai; Kanae Gamo; Maiko Takiguchi; Rina Kurisu; Hideyuki Mototani; Yukihiko Ebisuno; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Ann Rheum Dis       Date:  2019-06-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.